How to Report Postoperative Outcomes After a Paediatric Cardiac Surgery ?
Pedia-Card
1 other identifier
observational
189
1 country
1
Brief Summary
Congenital heart disease is a common abnormality in newborns. The marked improvement in the surgical management of congenital heart disease has led to a reduction in postoperative mortality, historically a quality criterion for surgical and resuscitation management. With the improvement of medical knowledge and surgical techniques, mortality is no longer a single quality criterion for a center and the search for other quality criteria is essential.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedDecember 14, 2023
December 1, 2023
10 months
September 15, 2022
December 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective analysis of the quality criteria described in the literature after pediatric cardiac surgery by studying their behavior within a local cohort within the University Hospitals of Strasbourg
Files analysed retrospectively from January 01, 2010 to March 31, 2022 will be examined
Eligibility Criteria
Minor patients, under the age of 18 operated at the HUS between 01/01/2010 and 03/31/2022 for transposition surgery of the great vessels (arterial switch) with or without CIV; or isolated ventricular septal closure
You may qualify if:
- Minor patients, under the age of 18
- operated at the HUS between 01/01/2010 and 03/31/2022 for transposition surgery of the great vessels (arterial switch) with or without CIV; or isolated ventricular septal closure
- Child or holders of parental authority who do not object to the reuse of their data for scientific research purposes.
You may not qualify if:
- Transposition surgery of the great vessels associated with coarctation of the aorta, pulmonary stenosis or any other complex malformation
- Surgical technique different from the arterial switch for the transpositions of the great vessels
- Closure of interventricular communication associated with another complex heart malformation (tetralogy of Fallot, atrioventricular canal, right ventricle with double outlet, etc.)
- Child or holders of parental authority who have expressed their opposition to the reuse of their data for scientific research purposes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2022
First Posted
September 21, 2022
Study Start
September 1, 2022
Primary Completion
July 1, 2023
Study Completion
September 1, 2023
Last Updated
December 14, 2023
Record last verified: 2023-12